Rheumatoid vasculitis

Area of Science:

• Nephrology
• Rheumatology
• Immunology

Background:

• Immune-complex diseases present complex treatment challenges.
• Therapeutic apheresis, including plasmapheresis and leukapheresis, is increasingly explored for rheumatic conditions.

Purpose of the Study:

• To evaluate the efficacy and role of therapeutic plasmapheresis and leukapheresis in managing immune-complex diseases.
• To assess the utility of apheresis as a treatment modality for various rheumatic conditions.

Main Methods:

• Review of current literature and clinical observations on therapeutic plasmapheresis and leukapheresis.
• Analysis of established efficacy in specific hyperviscosity diseases, myasthenia gravis, Goodpasture's syndrome, RH sensitized pregnancies, and thrombotic thrombocytopenic purpura.

Main Results:

• Apheresis demonstrates established efficacy in Waldenstrom's macroglobulinemia, myasthenia gravis, Goodpasture's syndrome, RH sensitized pregnancies, and thrombotic thrombocytopenic purpura.
• In active rheumatoid arthritis, apheresis serves as a short-term measure, with questionable cost-effectiveness.
• Apheresis for rheumatoid vasculitis is considered a limited research tool for understanding disease mechanisms.

Conclusions:

• Mechanical removal of immune complexes via apheresis may require adjunctive immunosuppressive therapy to prevent immune complex rebound.
• Future research should focus on agents that initiate immune complex production, addressing the root cause rather than solely removing existing complexes.